Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Chronic treatment with antidepressants affects several proteins linked to neuroplasticity, particularly brain derived neurotrophic factor (BDNF): this leads eventually to their therapeutic effects. It is possible that also for putative early therapeutic onset, antidepressants may act by promoting cellular adaptations linked to neuroplasticity. Escitalopram, known to be already effective in preclinical models of depression after 7 days, allowed us to investigate whether two effective treatment regimens (7 and 21 days) may contribute to synaptic plasticity by acting on BDNF signalling. We focused our attention on two regulators of BDNF transcription, CREB and CaRF (calcium responsive factor), and on kinases, CaMKII, ERK1/2 and p38 MAPK, linked to BDNF that play a distinctive role in synaptic plasticity. We evaluated whether the effects of escitalopram on these targets may be different in brain areas involved in the depressive symptomatology (hippocampus, frontal and prefrontal cortex). Here we demonstrate that escitalopram regulates intracellular pathways linked to neuroplasticity at both the time points evaluated in an area-specific manner. While the two escitalopram-treatment regimens failed to affect gene expression in the rat frontal cortex, 7days of treatment with escitalopram activated intracellular pathways linked to BDNF and increased the levels of Pro-BDNF in the rat prefrontal cortex. Moreover, 21 days of treatment with escitalopram decreased CREB/BDNF signalling while increasing p38 levels in the rat hippocampus. Even if further experiments with different antidepressant strategies will be needed, our data suggest that escitalopram efficacy may be mediated by early and late effects on synaptic plasticity in selective brain areas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“In recent years more and more interest has focused on the molecular mechanisms involved in neuroplasticity for its possible implication in the treatment of major depression (Krishnan and Nestler, 2008).”
BackgroundRegulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., & Bonhoeffer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8856 · Cited by 1,426 · cited 3×
“, 2005) whereas, mature BDNF-TrkB signalling is essential for long-term potentiation (LTP) (Figurov et al., 1996; Korte et al., 1995; Patterson et al., 1996; Rex et al., 2007) in the hippocampus.”
BackgroundThe yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
Patterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233 · cited 3×
“, 2005) whereas, mature BDNF-TrkB signalling is essential for long-term potentiation (LTP) (Figurov et al., 1996; Korte et al., 1995; Patterson et al., 1996; Rex et al., 2007) in the hippocampus.”
BackgroundCleavage of proBDNF by tPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity
Pang, P. T., Teng, H. K., Zaitsev, E., Woo, N. T., Sakata, K., Zhen, S., Teng, K. K., Yung, W.-H., Hempstead, B. L., & Lu, B. (2004) · Science · doi:10.1126/science.1100135 · Cited by 1,136
Figurov, A., Pozzo-Miller, L. D., Olafsson, P., Wang, T., & Lu, B. (1996) · Nature · doi:10.1038/381706a0 · Cited by 1,106 · cited 3×
“, 2005) whereas, mature BDNF-TrkB signalling is essential for long-term potentiation (LTP) (Figurov et al., 1996; Korte et al., 1995; Patterson et al., 1996; Rex et al., 2007) in the hippocampus.”
BackgroundConner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., & Varon, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02295.1997 · Cited by 1,097 · cited 2×
“In our experiment, the lack of correspondence between escitalopram-induced effects on BDNF mRNA and protein, could be due to a reduced BDNF turnover as well as to mechanisms of anterograde axonal transport (Conner et al., 1997).”
BackgroundKoenigs, M., & Grafman, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.004 · Cited by 956 · cited 1×
“In particular depression has been associated with ventromedial prefrontal cortex (vmPFC) hyperactivity and dorsolateral prefrontal cortex (dlPFC) hypoactivity, whereas recovery from depression has been associated with decreased vmPFC activity and increased dlPFC activity (Koenigs and Grafman, 2009).”
BackgroundActivation of p75NTR by proBDNF facilitates hippocampal long-term depression
Woo, N. H., Teng, H. K., Siao, C.-J., Chiaruttini, C., Pang, P. T., Milner, T. A., Hempstead, B. L., & Lu, B. (2005) · Nature Neuroscience · doi:10.1038/nn1510 · Cited by 815 · cited 3×
“Namely, Pro-BDNF-p75 signalling seems to be critical for long-term depression (LTD) (Rösch et al., 2005; Woo et al., 2005) whereas, mature BDNF-TrkB signalling is essential for long-term potentiation (LTP) (Figurov et al.”
BackgroundInteraction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793 · cited 4×
“It has been postulated that the prefrontal cortex and the hippocampus are key sites where ADs exert their therapeutic effects by affecting the serotonergic system (Mayberg, 2003; Martinowich and Lu, 2008).”
BackgroundMethodInfluentialNeurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression
Drevets, W. C. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26027-5 · Cited by 659 · cited 1×
“Functional imaging and brain stimulation studies provide convergent and compelling evidence that prefrontal cortex plays a role in the pathophysiology of depression (Drevets, 2000; Holmes and Wellman, 2009).”
BackgroundCelada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497 · cited 2×
“In fact, the prefrontal cortex sends descending projections to serotonergic (Celada et al., 2001), noradrenergic (Arnsten and Goldman-Rakic, 1984; Jodo et al.”
BackgroundThe Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · cited 2×
“Several independent lines of investigation have shown that CREB is affected by antidepressant treatments; moreover, among CREB regulated genes, BDNF stands out for its possible involvement in mood disorders and antidepressant effects (Blendy, 2006; Kozisek et al., 2008; Tardito et al., 2006).”
BackgroundMethodArnsten, A. F. T., & Goldman-Rakic, P. S. (1984) · Brain Research · doi:10.1016/0006-8993(84)90351-2 · Cited by 333 · cited 2×
“, 2001), noradrenergic (Arnsten and Goldman-Rakic, 1984; Jodo et al., 1998), dopaminergic (Hollerman et al.”
BackgroundPotent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons
Jodoj, E., Chiang, C., & Aston-Jones, G. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00372-2 · Cited by 321
Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · cited 2×
“Several independent lines of investigation have shown that CREB is affected by antidepressant treatments; moreover, among CREB regulated genes, BDNF stands out for its possible involvement in mood disorders and antidepressant effects (Blendy, 2006; Kozisek et al., 2008; Tardito et al., 2006).”
BackgroundRole of the brain‐derived neurotrophic factor at glutamatergic synapses
Carvalho, A. L., Caldeira, M. V., Santos, S. D., & Duarte, C. B. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707509 · Cited by 290
Gourley, S. L., Wu, F. J., Kiraly, D. D., Ploski, J. E., Kedves, A. T., Duman, R. S., & Taylor, J. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.016 · Cited by 287
Pro-BDNF–induced synaptic depression and retraction at developing neuromuscular synapses
Yang, F., Je, H.-S., Ji, Y., Nagappan, G., Hempstead, B., & Lu, B. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811147 · Cited by 130 · cited 3×
“Recent studies have demonstrated that CNS neurons primarily secrete Pro-BDNF in response to depolarization (Bergami et al., 2008; Nagappan et al., 2009; Yang et al., 2009).”
BackgroundCytokines, p38 MAP kinase and the pathophysiology of depression
Miller, A. H., & Raison, C. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301032 · Cited by 39
Cited by
Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal
Hanson, N. D., Owens, M. J., & Nemeroff, C. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.220 · Cited by 301
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207
Self-citationZhong, H., Haddjeri, N., & Sánchez, C. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2463-5 · Cited by 105
“More recently, it was reported that 1 week of escitalopram increased BDNF messenger RNA (mRNA) and pro-BDNF protein levels in prefrontal cortical regions in normal rats, while a 3-week escitalopram administration decreased BDNF mRNA levels as well as CREB/BDNF signaling in the hippocampus (Alboni et al. 2010).”
Neuroplasticity and the next wave of antidepressant strategies
Hayley, S., & Litteljohn, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00218 · Cited by 92
“Further, while one week of escitalopram increased BDNF mRNA, three weeks led to a reduction of transcript levels in the hippocampus (Alboni et al., 2010). These findings clearly contrast with other studies demonstrating antidepressant drug-induced elevations of BDNF both in the basal state and in response to chronic s…”
BackgroundResultInfluentialDionisie, V., Ciobanu, A. M., Toma, V. A., Manea, M. C., Baldea, I., Olteanu, D., Sevastre-Berghian, A., Clichici, S., Manea, M., Riga, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147483 · Cited by 78
Metadata
- Authors
- Alboni, S., Benatti, C., Capone, G., Corsini, D., Caggia, F., Tascedda, F., Mendlewicz, J., & Brunello, N.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 643
- Issue
- 2-3
- Pages
- 180-187
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2131637814
- Cited by
- 61
- References
- 24
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.